|
Volumn 62, Issue 1, 2010, Pages 49-56
|
First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALISKIREN;
AMIDE;
ANTIHYPERTENSIVE AGENT;
FUMARIC ACID DERIVATIVE;
RENIN;
ADOLESCENT;
ADULT;
AGED;
BLOOD;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
HUMAN;
HYPERTENSION;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PHARMACOKINETICS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
TIME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
AMIDES;
ANTIHYPERTENSIVE AGENTS;
FUMARATES;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
PHARMACOKINETICS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RENIN;
RENIN-ANGIOTENSIN SYSTEM;
TIME FACTORS;
|
EID: 79952199383
PISSN: 00194832
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|